{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:31:58Z","timestamp":1790217118104,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074325"],"award-info":[{"award-number":["82074325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.phymed.2023.154829","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:31:49Z","timestamp":1682109109000},"page":"154829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The efficacy of sodium ferulate combination therapy in coronary heart disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-5488","authenticated-orcid":false,"given":"Zinuo","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv. Res."},{"issue":"11","key":"10.1016\/j.phymed.2023.154829_bib0002","first-page":"397","article-title":"Novel antithrombotic agents in ischemic cardiovascular disease: progress in the search for the optimal treatment","volume":"9","author":"Barriuso","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2023.154829_bib0003","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pcad.2016.04.003","article-title":"Coronary atherosclerosis: pathophysiologic basis for diagnosis and management","volume":"58","author":"Boudoulas","year":"2016","journal-title":"Grog. Cardiovasc. Dis."},{"key":"10.1016\/j.phymed.2023.154829_bib0004","unstructured":"Cai, K.Z., 1997. The invention relates to a method for preparing ferulic acid, sodium ferulate and sterol from ferulate ester. CN Patent No 1034328C. China, Beijing: Patent Office of the People's Republic."},{"issue":"13","key":"10.1016\/j.phymed.2023.154829_bib0005","first-page":"184","article-title":"Clinical observation of sodium ferulate injection in the treatment of senile unstable angina pectoris","volume":"7","author":"Chen","year":"2012","journal-title":"China Pract. Med."},{"key":"10.1016\/j.phymed.2023.154829_bib0006","unstructured":"China National Medical Products Administration, 2022. sodium ferulate. https:\/\/www.nmpa.gov.cn\/ [Accessed September 29, 2022]."},{"key":"10.1016\/j.phymed.2023.154829_bib0007","series-title":"Chinese Pharmacopoeia","first-page":"712","year":"2020"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0008","doi-asserted-by":"crossref","first-page":"e22004","DOI":"10.1002\/jbt.22004","article-title":"In vitro and in vivo antithrombotic and cytotoxicity effects of ferulic acid","volume":"32","author":"Choi","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0009","first-page":"49","article-title":"Features of the organization of activities in the field of prevention of cardiovascular disease","volume":"13","author":"Daurbekov","year":"2022","journal-title":"J. Comput. Med. Res."},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.suc.2022.01.007","article-title":"Epidemiology of coronary artery disease","volume":"102","author":"Duggan","year":"2022","journal-title":"Surg. Clin. N. Am."},{"key":"10.1016\/j.phymed.2023.154829_bib0011","unstructured":"Fu, Y.J., He, M., 2004. Protective effect and mechanism of pharmacologic preconditioning induced by sodium ferulate on primary cultured myocardial cell injury by anoxia\/reoxygenation. Yao xue xue bao. 39 (5), 325\u2013327. PMID: 15338871."},{"issue":"9963","key":"10.1016\/j.phymed.2023.154829_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2023.154829_bib0013","unstructured":"Guo, J., Lin, H., Wang, F., Lin, Y.Z., Zhao, Y.L., Wang, X.Y., Jiao, W., 2004. The Interference of sodium ferulate in endothelium function after PCI. Guangxi Yixue. 26 (10), 1418\u20131421. doi: 10.3969\/j.issn.0253-4304.2004.10.009."},{"issue":"4","key":"10.1016\/j.phymed.2023.154829_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"14","key":"10.1016\/j.phymed.2023.154829_bib0015","first-page":"1426","article-title":"Investigation of the effect of ferulic acid in Leonurus japonicas on the quality standard of Chinese patent drug","volume":"39","author":"He","year":"2019","journal-title":"Zhongguo Yiyuan Yaoxue Zazhi"},{"key":"10.1016\/j.phymed.2023.154829_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.01.005","article-title":"Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling","volume":"777","author":"Hong","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.phymed.2023.154829_bib0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.07.107","article-title":"Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II","volume":"499","author":"Hou","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2023.154829_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3754942","article-title":"Sodium ferulate protects against angiotensin II-induced cardiac hypertrophy in mice by regulating the MAPK\/ERK and JNK pathways","volume":"2017","author":"Hu","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"16","key":"10.1016\/j.phymed.2023.154829_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025608","article-title":"Traditional Chinese medicine injection for promoting blood circulation and removing blood stasis in treating angina pectoris of coronary heart disease: a protocol for systematic review and network meta-analysis","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine"},{"issue":"15","key":"10.1016\/j.phymed.2023.154829_bib0021","first-page":"75","article-title":"Sodium ferulate in the treatment of plasma PAPP-A, NF-\u03baB in patients with coronary heart disease and diabetes","volume":"56","author":"Huang","year":"2016","journal-title":"Shandong Yiyao"},{"issue":"8","key":"10.1016\/j.phymed.2023.154829_bib0022","first-page":"32","article-title":"Effect of sodium ferulate on hemorheology of elderly patients with coronary heart disease","volume":"6","author":"Huang","year":"2005","journal-title":"Shiyong Linchuang Yixue"},{"key":"10.1016\/j.phymed.2023.154829_bib0023","unstructured":"Hubei Renmin Pharmaceutical. Co., LTD., 2021. The invention relates to a preparation method of freeze-dried powder injection for sodium ferulate. CN Patent No 112472674A. China, Beijing: Patent Office of the People's Republic."},{"issue":"7","key":"10.1016\/j.phymed.2023.154829_bib0024","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1172\/JCI123825","article-title":"Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure","volume":"129","author":"Iring","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin. Trials"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","article-title":"Endothelin-1 levels and cardiovascular events","volume":"30","author":"Jankowich","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"16","key":"10.1016\/j.phymed.2023.154829_bib0028","first-page":"3105","article-title":"Analysis of the efficacy of sodium ferulate in treating unstable angina pectoris","volume":"6","author":"Ji","year":"2006","journal-title":"Zhongguo Wuzhenxue Zazhi"},{"key":"10.1016\/j.phymed.2023.154829_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4967318","article-title":"Sodium ferulate attenuates lidocaine-induced corneal endothelial impairment","volume":"2018","author":"Jiang","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"issue":"12","key":"10.1016\/j.phymed.2023.154829_bib0030","first-page":"1807","article-title":"Study on protective effect and mechanism of sodium ferulate on myocardium in patients with acute myocardial infarction undergoing primary PCI","volume":"35","author":"Lai","year":"2019","journal-title":"J. Mod. Med. Health"},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.imbio.2015.11.001","article-title":"The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated Raw 264.7 cells","volume":"221","author":"Lampiasi","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.phymed.2023.154829_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0033","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0960327120950006","article-title":"Influence of sodium ferulate on miR-133a and left ventricle remodeling in rats with myocardial infarction","volume":"40","author":"Li","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.phymed.2023.154829_bib0034","article-title":"Integrative western and chinese medicine on coronary heart disease: where is the orientation?","author":"Li","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"7","key":"10.1016\/j.phymed.2023.154829_bib0035","first-page":"492","article-title":"Effect of sodium ferulate on leucocyte spontaneous activation and surface adhesion molecule expression in arteriosclerosis","volume":"21","author":"Li","year":"2001","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2023.154829_bib0037","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpba.2014.07.007","article-title":"Comparative analysis of main aromatic acids and phthalides in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and Fo-Shou-San by a validated UHPLC\u2013TQ-MS\/MS","volume":"99","author":"Li","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2023.154829_bib0038","unstructured":"Li, X.J., 2011.Protection of ferulic acid on lipopolysaccharide-inducedpreterm delivery and glucuronidation and sulfation of ferulic acid. [dissertation\/doctor's thesis]. [China (WH)]: Wuhan Univ. https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=3uoqIhG8C447WN1SO36whHG-SvTYjkCc7dJWN_daf9c2-IbmsiYfKiLj-nQmikvfevrQw-gWqh7j4SuLJEbNHEZuh5Hzoi9n."},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0039","first-page":"742","article-title":"Effect of sodium feruate on unstable angina","volume":"38","author":"Li","year":"2010","journal-title":"Linchuang Junyi Zazhi"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0040","first-page":"27","article-title":"The efficacy of sodium ferulate in treating the patients with unstable angina","volume":"36","author":"Lian","year":"2010","journal-title":"J. Mod. Clin. Med."},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0041","first-page":"233","article-title":"Protective effect of sodium ferulate on endothelial function after percutaneous transluminal coronary angioplasty","volume":"24","author":"Lin","year":"2004","journal-title":"Zhongguo Laonianxue Zazhi"},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0042","first-page":"327","article-title":"Effect of sodium ferulate on inflammatory cytokines in patients with coronary heart disease and angina pectoris","volume":"15","author":"Lin","year":"2008","journal-title":"Zhongguo Zhongyiyao Keji"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0043","first-page":"46","article-title":"Analysis of the clinical value of sodium ferulate in the treatment of coronary heart disease","volume":"27","author":"Lin","year":"2016","journal-title":"Xiandai Zhenduan Yu Zhiliao"},{"issue":"20","key":"10.1016\/j.phymed.2023.154829_bib0044","first-page":"35","article-title":"Effect of sodium ferulate treatment on plasma NO and endothelin-1 concentrations in CAD patients","volume":"13","author":"Liu","year":"2015","journal-title":"Shequ Yixue Zazhi"},{"issue":"14","key":"10.1016\/j.phymed.2023.154829_bib0046","first-page":"987","article-title":"Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts","volume":"86","author":"Liu","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"28","key":"10.1016\/j.phymed.2023.154829_bib0047","first-page":"52","article-title":"Clinical observation of 56 cases of unstable angina pectoris treated with sodium ferulate for injection","volume":"6","author":"Liu","year":"2009","journal-title":"Zhongguo Yiyao Daobao"},{"issue":"11","key":"10.1016\/j.phymed.2023.154829_bib0048","first-page":"63","article-title":"Clinical efficacy of sodium ferulate in treating angina pectoris","volume":"9","author":"Liu","year":"2014","journal-title":"China J. Pharm. Econ."},{"issue":"9","key":"10.1016\/j.phymed.2023.154829_bib0049","first-page":"80","article-title":"Clinical observation of sodium ferulate in the treatment of unstable angina pectoris","volume":"33","author":"Liu","year":"2006","journal-title":"Chin J. Pract. Med."},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/FJC.0000000000001277","article-title":"Sodium ferulate inhibits rat cardiomyocyte hypertrophy induced by angiotensin II through enhancement of endothelial nitric oxide synthase\/nitric oxide\/cyclic guanosine monophosphate signaling pathway","volume":"80","author":"Luo","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0051","first-page":"190","article-title":"Efficacy of sodium ferulate in treating stable angina pectoris","volume":"24","author":"Lv","year":"2010","journal-title":"J. Changzhi Med. Coll."},{"issue":"10","key":"10.1016\/j.phymed.2023.154829_bib0052","first-page":"602","article-title":"Effect of the endothelin receptor antagonist sodium ferulate on endothelial function and restenosis after PCI","volume":"8","author":"Ma","year":"2009","journal-title":"Yinanbing Zazhi"},{"issue":"8","key":"10.1016\/j.phymed.2023.154829_bib0053","first-page":"452","article-title":"Effect of sodium ferulate on blood lipid levels and angina pectoris in patients with coronary heart disease","volume":"27","author":"Ma","year":"2014","journal-title":"Med. Inf."},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0054","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1248\/bpb.33.29","article-title":"Ferulic acid protects human umbilical vein endothelial cells from radiation induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways","volume":"33","author":"Ma","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2023.154829_bib0056","unstructured":"NanYang Medical College, 2015. Regulation of CXCL1 gene by sodium ferulate in the prevention and treatment of arteriosclerosis. CN Patent No 104306365A. China, Beijing: Patent Office of the People's Republic."},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0058","first-page":"128","article-title":"Prevention of restenosis after percutaneous coronary intervention by sodium ferulate","volume":"26","author":"Niu","year":"2007","journal-title":"Zhongguo Xinyao Yu Linchuang Zazhi"},{"key":"10.1016\/j.phymed.2023.154829_bib0059","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-018-0699-4","article-title":"Registration of systematic reviews in PROSPERO: 30,000 records and counting","volume":"7","author":"Page","year":"2018","journal-title":"Syst. Rev."},{"issue":"4","key":"10.1016\/j.phymed.2023.154829_bib0061","first-page":"30","article-title":"The old 20 patients with unstable angina treatment analysis","volume":"3","author":"Pan","year":"2009","journal-title":"Chin J. Mod. Drug Appl."},{"key":"10.1016\/j.phymed.2023.154829_bib0062","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3389\/fimmu.2020.02126","article-title":"How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression","volume":"11","author":"Rajab","year":"2020","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.phymed.2023.154829_bib0063","first-page":"2699","article-title":"Effecacy of sodium ferulate in treating patients with unstable angina pectoris and its underlying mechanism","volume":"15","author":"Ren","year":"2012","journal-title":"Zhongguo Quanke Yixue"},{"issue":"10","key":"10.1016\/j.phymed.2023.154829_bib0064","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 signaling in heart disease","volume":"9","author":"Rolski","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1476-5381.2009.00324.x","article-title":"NCX 2057, a novel NO-releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in in vitro and in vivo models","volume":"158","author":"Ronchetti","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2023.154829_bib0066","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.fct.2019.01.034","article-title":"Wheat phenolics suppress doxorubicin-induced cardiotoxicity via inhibition of oxidative stress, MAP kinase activation, NF-\u03baB pathway, PI3K\/Akt\/mTOR impairment, and cardiac apoptosis","volume":"125","author":"Sahu","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0068","first-page":"570","article-title":"Improvement of the industrial synthesis process of the sodium ferulate","volume":"27","author":"Shang","year":"2016","journal-title":"Huaxue Yanjiu"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0069","first-page":"62","article-title":"The characteristics of impaired functions and life limitations of disabled people due to coronary heart disease","volume":"29","author":"Shmakova","year":"2022","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"issue":"23","key":"10.1016\/j.phymed.2023.154829_bib0070","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.3390\/ijms222312889","article-title":"Recent advances in biological activity, new formulations and prodrugs of ferulic acid","volume":"22","author":"Stompor-Gor\u0105cy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0071","first-page":"49","article-title":"Sodium ferulate combined with nitroglycerin treated unstable angina pectoris in 40 cases","volume":"24","author":"Sun","year":"2005","journal-title":"Yiyao Daobao"},{"key":"10.1016\/j.phymed.2023.154829_bib0072","series-title":"Proceedings of the 6th National Toxicology Conference of the Chinese Society of Toxicology","first-page":"91","article-title":"Long-term toxicity of dexamethasone and compound sodium ferulate and oxymatrine after intraperitoneal injection for 3 weeks in mice","author":"Sun","year":"2013"},{"issue":"7","key":"10.1016\/j.phymed.2023.154829_bib0073","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1002\/jcp.27945","article-title":"Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors","volume":"234","author":"Tajfard","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.phymed.2023.154829_bib0074","first-page":"507","article-title":"Effects of ferulic acid and its derivatives on survival rate of irradiated mice","volume":"30","author":"Tan","year":"2014","journal-title":"Jiefangjun Yaoxue Xuebao"},{"issue":"7","key":"10.1016\/j.phymed.2023.154829_bib0075","first-page":"1407","article-title":"Effect and efficacy analysis of sodium ferulate on vascular endothelial function in patients with coronary heart disease","volume":"31","author":"Tang","year":"2014","journal-title":"Yixue Linchuang Yanjiu"},{"issue":"10","key":"10.1016\/j.phymed.2023.154829_bib0076","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4244\/EIJV8I10A176","article-title":"Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial","volume":"8","author":"Tobbia","year":"2013","journal-title":"Eurointervention"},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0077","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","article-title":"Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6","volume":"18","author":"Tyrrell","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phymed.2023.154829_bib0078","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.btre.2015.08.008","article-title":"Biomedical applications of ferulic acid encapsulated electrospun nanofibers","volume":"8","author":"Vashisth","year":"2015","journal-title":"Biotechnol. Rep."},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0079","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1527-3466.2005.tb00163.x","article-title":"Pharmacological actions of sodium ferulate in cardiovascular system","volume":"23","author":"Wang","year":"2005","journal-title":"Cardiovasc. Drug Rev."},{"issue":"4","key":"10.1016\/j.phymed.2023.154829_bib0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00005344-200404000-00010","article-title":"Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits","volume":"43","author":"Wang","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phymed.2023.154829_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172417","article-title":"A novel ferulic acid derivative attenuates myocardial cell hypoxia reoxygenation injury through a succinate dehydrogenase dependent antioxidant mechanism","volume":"856","author":"Wang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2023.154829_bib0082","first-page":"623","article-title":"Influence of sodium ferulate injection on the level of endothelin and nitric oxide in patients with unstable angina and the curative effects","volume":"10","author":"Wang","year":"2007","journal-title":"Zhongguo Quanke Yixue"},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0083","first-page":"343","article-title":"Effect of sodium ferulate on pulmonary artery pressure, plasma endothelin-1 and d-dimer in patients with chronic pulmonary heart disease","volume":"18","author":"Wang","year":"2001","journal-title":"Linchuang Neike Zazhi"},{"issue":"7 Suppl","key":"10.1016\/j.phymed.2023.154829_bib0084","first-page":"82","article-title":"48 cases of unstable angina pectoris treated with sodium ferulate","volume":"25","author":"Wang","year":"2006","journal-title":"Yiyao Daobao"},{"issue":"11","key":"10.1016\/j.phymed.2023.154829_bib0085","first-page":"586","article-title":"Effects of sodium feruvate on the C-reactive protein and von Willebrand factor in patients with unstable angina pectoris","volume":"41","author":"Wang","year":"2012","journal-title":"Shanxi Yiyao Zazhi"},{"issue":"6","key":"10.1016\/j.phymed.2023.154829_bib0086","first-page":"823","article-title":"Clinical observation and mechanism of sodium ferulate injection in the treatment of viral myocarditis","volume":"34","author":"Wang","year":"2012","journal-title":"Hebei J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0087","first-page":"430","article-title":"Sodium ferulate is an inhibitor of thromboxane A2 synthetase","volume":"9","author":"Wang","year":"1988","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"11","key":"10.1016\/j.phymed.2023.154829_bib0088","first-page":"38","article-title":"The efficacy of sodium ferulate on coronary heart disease and its effect on vascular endothelial function","author":"Wei","year":"2016","journal-title":"Prev. Treat Cardiovasc."},{"issue":"9","key":"10.1016\/j.phymed.2023.154829_bib0089","first-page":"555","article-title":"Effect of sodium ferulate injection on superoxide dismutase, lipid peroxide, and fibrinolysis system in patients with coronary disease","volume":"5","author":"Wen","year":"2002","journal-title":"Zhongguo Zhiye Yaoshi"},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1471-4159.2004.02359.x","article-title":"Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid","volume":"89","author":"Wenk","year":"2004","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phymed.2023.154829_bib0091","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacl.2021.09.046","article-title":"Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group","volume":"15","author":"Wilson","year":"2021","journal-title":"J. Clin. Lipidol."},{"issue":"D1","key":"10.1016\/j.phymed.2023.154829_bib0092","doi-asserted-by":"crossref","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","article-title":"SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping","volume":"47","author":"Wu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2023.154829_bib0093","unstructured":"Wuhan Changlian Laifu Pharmaceutical Co., LTD., 2019. The invention relates to sodium ferulate controlled-release tablets and a preparation method. CN Patent No 110025589A. China, Beijing: Patent Office of the People's Republic."},{"issue":"1","key":"10.1016\/j.phymed.2023.154829_bib0094","first-page":"86","article-title":"Clinical observation of sodium ferulate in the treatment of unstable angina pectoris","volume":"4","author":"Xiao","year":"2006","journal-title":"Chin. J. Integr. Med. Cardio Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.phymed.2023.154829_bib0095","first-page":"86","article-title":"Efficacy observation on sodium ferulate on 160 cases of unstable angina pectoris","volume":"16","author":"Xiong","year":"2005","journal-title":"Xiandai Zhenduan Yu Zhiliao"},{"key":"10.1016\/j.phymed.2023.154829_bib0096","unstructured":"Xu, S., 2005. Studies on the photodegradation kinetics of sodium ferulate and the in vivo pharmacokinetics of its sustained-release preparations. [dissertation\/master's thesis]. [China (SH)]: Naval Med Univ. doi: 10.7666\/d.y730365."},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0097","first-page":"15","article-title":"Clinical observation of 40 cases of elderly CHD treated with sodium ferulate","volume":"5","author":"Yang","year":"2003","journal-title":"J. Mil. Surg. Southwest China"},{"issue":"6","key":"10.1016\/j.phymed.2023.154829_bib0098","first-page":"421","article-title":"A compared observation of sodium ferulate for treatment of unstable angina pectoris","volume":"18","author":"Yang","year":"2001","journal-title":"Xinxiang Yixueyuan Xuebao"},{"issue":"3","key":"10.1016\/j.phymed.2023.154829_bib0099","article-title":"Conventional medication combined with sodium ferulate in CAD angina pectoris in 52 cases","volume":"14","author":"Yang","year":"2002","journal-title":"Tianjin Pharm"},{"issue":"2\u20133","key":"10.1016\/j.phymed.2023.154829_bib0100","first-page":"55","article-title":"The treatment of cardiovascular diseases: a review of ferulic acid and its derivatives","volume":"76","author":"Zhang","year":"2021","journal-title":"Pharmazie"},{"issue":"10","key":"10.1016\/j.phymed.2023.154829_bib0101","first-page":"120","article-title":"Curative effect of sodium ferulate on 120 patients with unstable angina pectoris","volume":"23","author":"Zhao","year":"2010","journal-title":"Linchuang Wuzhen Wuzhi"},{"issue":"4","key":"10.1016\/j.phymed.2023.154829_bib0102","first-page":"78","article-title":"Sodium ferulate combined with isosorbide dinitrate in the treatment of unstable angina pectoris","volume":"28","author":"Zhao","year":"2007","journal-title":"J. Med. Forum"},{"key":"10.1016\/j.phymed.2023.154829_bib0103","unstructured":"Zhao, Z., 2011. Effect of the endothelin antagonist sodium ferulate on artery elasticity and blood nitric oxide, C-reactive protein, cystatin C in patients with unstable angina. [dissertation\/master's thesis]. [China (SD)]: Shandong Univ. doi: 10.7666\/d.y1938356."},{"issue":"6","key":"10.1016\/j.phymed.2023.154829_bib0104","first-page":"451","article-title":"Determianation of plasma concentration of sodium ferulate by HPLC and study on its pharmacokinetics in Beagle dogs","volume":"27","author":"Zhou","year":"2009","journal-title":"Yaoxue Shijian Zazhi"},{"key":"10.1016\/j.phymed.2023.154829_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2017.10.008","article-title":"Ferulic acid relaxed rat aortic, small mesenteric and coronary arteries by blocking voltage-gated calcium channel and calcium desensitization via dephosphorylation of ERK1\/2 and MYPT1","volume":"815","author":"Zhou","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.phymed.2023.154829_bib0106","first-page":"11","article-title":"Influence of sodium ferulate injection on levels of blood lipid, nitric oxide and endothelin-1 in patients with coronary heart disease","volume":"18","author":"Zhu","year":"2014","journal-title":"Shiyong Linchuang Yiyao Zazhi"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:45:53Z","timestamp":1760553953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711323001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":99,"alternative-id":["S0944711323001903"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154829","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of sodium ferulate combination therapy in coronary heart disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154829"}}